A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer

Icli, F; AKBULUT, HAKAN; Dincol, D; Onur, H; DEMİRKAZIK, AHMET; Cam, R; Cay, F; Demirci, S; Uner, A; Erekul, S

doi:10.1023/a:1011118004629

A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer

Icli F., AKBULUT H., Dincol D., Onur H., DEMİRKAZIK A., Cam R., ...More

ANNALS OF ONCOLOGY, vol.12, no.7, pp.1011-1013, 2001 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 12 Issue: 7
Publication Date: 2001
Doi Number: 10.1023/a:1011118004629
Journal Name: ANNALS OF ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1011-1013
Keywords: adjuvant chemotherapy, adriamycin, breast cancer, cisplatin, cyclophosphamide, etoposide, CHEMOTHERAPY, DOXORUBICIN
Lokman Hekim University Affiliated: No

Abstract

Background: Four cycles of AC have been accepted as the standard chemotherapy in breast cancer. In the present randomized study we aimed to assess the efficacy of adjuvant etoposide + cisplatin (EP) combination following four cycles of standard adriamycin + cyclophosphamide (AC) in premenopausal patients with operable breast cancer and axillary lymph node metastasis.